As of 2026-10-04, the Fair Value of Adaptive Biotechnologies Corp (ADPT) is -3.29 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 28.35 USD, the upside of Adaptive Biotechnologies Corp is -111.61%.
With the market price of 28.35 USD and our fair value calculation, Adaptive Biotechnologies Corp (ADPT) is not a good investment. Investing in ADPT stocks now will result in a potential loss of 111.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -207.30 | -200.20 | -225.25 | -159.49 | -59.50 | -170.35 |
| YoY growth | -41.79% | 3.42% | -12.51% | 29.19% | 62.69% | 8.20% |
| Market Cap (mil) | 4,509.35 |
| P/E | |
| Forward P/E |
| EPS | -0.40 |
| Avg earnings growth rate | 8.20% |
| TTM earnings | -63.85 |